Prospective Pilot Study of the treatment of compression of median nerve neuropathy with Nucleo CMP Forte®.

Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge0 个研究点开始时间: 2014年9月9日最近更新: 2014年11月3日

适应症

试验速览

暂无简介。

•1) Patients between 18 and 80 years old.
•2) Patients clinically and electrophysiological diagnosed with CTS, who won?t require a premature surgical procedure.
•3) Patients able to understand the study objective and able to give the Inform Consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 40
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 10

•1) Pregnant or breastfeeding woman.
•2) Patients with high probablility os not completing the study requirements according to the investigator criteria.
•3) Patients with dysphagia which won?t allow them to take the study medication.
•4) Patients diagnosed with neuropathy which is causing an axonal degeneration.
•5) Patients with a recent forearm trauma.
•6) Patients participating in antother Clinical Trial.

发起方

Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge